NCT04523272 2024-10-15A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal CancerChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3 Active not recruiting528 enrolled